NewAmsterdam Pharma Co N.V. SEC filings NAMSW
NewAmsterdam Pharma Co N.V. has 415 filings in SEC EDGAR's recent list, going back to Aug 4, 2022. Its latest annual report, Form ARS, was filed on May 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K | Current report | Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Other events
|
Sep 29, 2026 | Sep 29, 2026 |
| 8-K |
Current report
Other events
|
Sep 21, 2026 | Sep 21, 2026 |
| 8-K/A |
Amended current report
Officer or director change
|
Aug 14, 2026 | Jul 16, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 14, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Other events
|
Jul 24, 2026 | Jul 24, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 22, 2026 | Jul 16, 2026 |
| S-8 | Employee stock plan registration | Jun 5, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 3, 2026 | Jun 2, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| ARS | Annual report to shareholders | May 6, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | May 6, 2026 | May 6, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 24, 2026 | Apr 20, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 20, 2026 | Apr 20, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 2, 2026 | Mar 2, 2026 |
| S-8 | Employee stock plan registration | Feb 18, 2026 | — |
| 10-K | Annual report | Feb 18, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 18, 2026 | Feb 18, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 9, 2026 | Jan 9, 2026 |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 5, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 2, 2025 | Sep 2, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 18, 2025 | Aug 18, 2025 |
| 8-K |
Current report
Material agreement
|
Aug 15, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 30, 2025 | Jul 30, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 11, 2025 | Jul 11, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 11, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 9, 2025 | Jun 9, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2025 | Jun 4, 2025 |
| ARS | Annual report to shareholders | May 8, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | May 8, 2025 | Jun 4, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 7, 2025 | May 7, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 28, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 17, 2025 | Apr 15, 2025 |
| EFFECT | Filing | Mar 10, 2025 | — |
| 424B3 | Prospectus | Mar 10, 2025 | — |
| CORRESP | Letter to the SEC | Mar 6, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 4, 2025 | — |
| S-3 | Shelf registration | Feb 28, 2025 | — |
| 10-K | Annual report | Feb 26, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2025 | Feb 26, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2025 | Jan 10, 2025 |
| S-8 | Employee stock plan registration | Jan 7, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Dec 13, 2024 | Dec 11, 2024 |
| 424B5 | Prospectus supplement | Dec 13, 2024 | — |
| S-3MEF | Filing | Dec 11, 2024 | — |
| 424B5 | Prospectus supplement | Dec 10, 2024 | — |
| 8-K |
Current report
Other events
|
Dec 10, 2024 | Dec 10, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 10, 2024 | Dec 10, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 20, 2024 | Nov 20, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 18, 2024 | Nov 18, 2024 |
| 10-Q | Quarterly report | Nov 6, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| UPLOAD | Letter from the SEC | Nov 1, 2024 | — |
| 20-F/A | Amended annual report (foreign issuer) | Oct 28, 2024 | Dec 31, 2022 |
| 8-K |
Current report
Restatement
|
Oct 18, 2024 | Oct 18, 2024 |
| CORRESP | Letter to the SEC | Oct 18, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 30, 2024 | — |
| EFFECT | Filing | Aug 12, 2024 | — |
| POS AM | Filing | Aug 9, 2024 | — |
| 8-K |
Current report
Other events
|
Aug 9, 2024 | Aug 9, 2024 |
| 424B5 | Prospectus supplement | Aug 9, 2024 | — |
| CORRESP | Letter to the SEC | Aug 8, 2024 | — |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 29, 2024 | Jul 29, 2024 |
| UPLOAD | Letter from the SEC | Jul 25, 2024 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 18, 2024 | Jul 16, 2024 |
| EFFECT | Filing | Jul 12, 2024 | — |
| CORRESP | Letter to the SEC | Jul 9, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2024 | — |
| S-8 | Employee stock plan registration | Jul 3, 2024 | — |
| S-3 | Shelf registration | Jul 3, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 11, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 7, 2024 | Jun 5, 2024 |
| ARS | Annual report to shareholders | May 9, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | May 9, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 29, 2024 | Jun 5, 2024 |
| 424B3 | Prospectus | Apr 19, 2024 | — |
| EFFECT | Filing | Apr 17, 2024 | — |
| POS AM | Filing | Apr 12, 2024 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 1, 2024 | Mar 28, 2024 |
| 424B3 | Prospectus | Mar 12, 2024 | — |
| EFFECT | Filing | Mar 8, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 4, 2024 | Mar 4, 2024 |
| POS AM | Filing | Feb 28, 2024 | — |
| 8-K |
Current report
Results of operations
|
Feb 28, 2024 | Feb 28, 2024 |
| 10-K | Annual report | Feb 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 15, 2024 | Feb 13, 2024 |
| 424B5 | Prospectus supplement | Feb 15, 2024 | — |
| 424B5 | Prospectus supplement | Feb 13, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 22, 2024 | Jan 22, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 8, 2024 | Jan 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 4, 2024 | Jan 4, 2024 |
| EFFECT | Filing | Dec 19, 2023 | — |
| 424B3 | Prospectus | Dec 19, 2023 | — |
| CORRESP | Letter to the SEC | Dec 15, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 15, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Dec 7, 2023 | — |
| 424B3 | Prospectus | Nov 13, 2023 | — |
| 6-K | Current report (foreign issuer) | Nov 13, 2023 | Nov 13, 2023 |
| 6-K | Current report (foreign issuer) | Oct 23, 2023 | Oct 23, 2023 |
| 6-K | Current report (foreign issuer) | Sep 25, 2023 | Sep 25, 2023 |
| 424B3 | Prospectus | Sep 21, 2023 | — |
| 6-K | Current report (foreign issuer) | Sep 21, 2023 | Sep 21, 2023 |
| 6-K | Current report (foreign issuer) | Aug 28, 2023 | Aug 28, 2023 |
| 424B3 | Prospectus | Aug 15, 2023 | — |
| 6-K | Current report (foreign issuer) | Aug 14, 2023 | Aug 14, 2023 |
| EFFECT | Filing | Aug 11, 2023 | — |
| POS AM | Filing | Aug 7, 2023 | — |
| 6-K | Current report (foreign issuer) | Aug 7, 2023 | Aug 7, 2023 |
| 6-K | Current report (foreign issuer) | Aug 7, 2023 | Jun 30, 2023 |
| 6-K | Current report (foreign issuer) | Jul 26, 2023 | Jul 26, 2023 |
| 424B3 | Prospectus | Jun 21, 2023 | — |
| 6-K | Current report (foreign issuer) | Jun 21, 2023 | Jun 21, 2023 |
| 424B3 | Prospectus | Jun 12, 2023 | — |
| 6-K | Current report (foreign issuer) | Jun 12, 2023 | Jun 9, 2023 |
| 424B3 | Prospectus | Jun 8, 2023 | — |
| 424B3 | Prospectus | Jun 6, 2023 | — |
| 6-K | Current report (foreign issuer) | Jun 5, 2023 | Jun 5, 2023 |
| 6-K | Current report (foreign issuer) | May 31, 2023 | May 31, 2023 |
| 424B3 | Prospectus | May 23, 2023 | — |
| 6-K | Current report (foreign issuer) | May 23, 2023 | May 23, 2023 |
| 424B3 | Prospectus | May 8, 2023 | — |
| 6-K | Current report (foreign issuer) | May 8, 2023 | May 8, 2023 |
| 424B3 | Prospectus | Apr 25, 2023 | — |
| EFFECT | Filing | Apr 24, 2023 | — |
| 6-K | Current report (foreign issuer) | Apr 24, 2023 | Apr 24, 2023 |
| POS AM | Filing | Apr 17, 2023 | — |
| 6-K | Current report (foreign issuer) | Apr 3, 2023 | Apr 3, 2023 |
| 20-F | Annual report (foreign issuer) | Mar 31, 2023 | Dec 31, 2022 |
| 6-K | Current report (foreign issuer) | Mar 31, 2023 | Mar 31, 2023 |
| S-8 | Employee stock plan registration | Mar 31, 2023 | — |
| 6-K | Current report (foreign issuer) | Mar 7, 2023 | Mar 7, 2023 |
| 6-K | Current report (foreign issuer) | Mar 3, 2023 | Mar 3, 2023 |
| 6-K | Current report (foreign issuer) | Feb 14, 2023 | Feb 14, 2023 |
| 6-K | Current report (foreign issuer) | Feb 6, 2023 | Feb 6, 2023 |
| 424B3 | Prospectus | Jan 31, 2023 | — |
| EFFECT | Filing | Jan 30, 2023 | — |
| CORRESP | Letter to the SEC | Jan 26, 2023 | — |
| 6-K | Current report (foreign issuer) | Jan 17, 2023 | Jan 17, 2023 |
| CORRESP | Letter to the SEC | Jan 17, 2023 | — |
| F-1/A | Filing | Jan 17, 2023 | — |
| 6-K | Current report (foreign issuer) | Jan 11, 2023 | Jan 11, 2023 |
| 6-K | Current report (foreign issuer) | Jan 9, 2023 | Jan 9, 2023 |
| UPLOAD | Letter from the SEC | Jan 5, 2023 | — |
| F-1 | Registration statement (foreign issuer) | Dec 20, 2022 | — |
| 6-K | Current report (foreign issuer) | Dec 19, 2022 | Dec 19, 2022 |
| 20-F | Annual report (foreign issuer) | Nov 28, 2022 | Nov 22, 2022 |
| 6-K | Current report (foreign issuer) | Nov 23, 2022 | Nov 23, 2022 |
| CERT | Filing | Nov 22, 2022 | — |
| 8-A12B | Filing | Nov 22, 2022 | — |
| 8-A12B | Filing | Nov 18, 2022 | — |
| 425 | Filing | Nov 16, 2022 | — |
| SEC STAFF LETTER | Filing | Oct 19, 2022 | — |
| EFFECT | Filing | Oct 18, 2022 | — |
| 424B3 | Prospectus | Oct 18, 2022 | — |
| 425 | Filing | Oct 17, 2022 | — |
| CORRESP | Letter to the SEC | Oct 14, 2022 | — |
| CORRESP | Letter to the SEC | Oct 13, 2022 | — |
| F-4/A | Filing | Oct 13, 2022 | — |
| 425 | Filing | Oct 13, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 12, 2022 | — |
| 425 | Filing | Oct 11, 2022 | — |
| 425 | Filing | Oct 5, 2022 | — |
| 425 | Filing | Oct 5, 2022 | — |
| 425 | Filing | Oct 4, 2022 | — |
| CORRESP | Letter to the SEC | Oct 3, 2022 | — |
| F-4/A | Filing | Oct 3, 2022 | — |
| 425 | Filing | Sep 29, 2022 | — |
| 425 | Filing | Sep 28, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 27, 2022 | — |
| 425 | Filing | Sep 23, 2022 | — |
| 425 | Filing | Sep 22, 2022 | — |
| 425 | Filing | Sep 21, 2022 | — |
| 425 | Filing | Sep 20, 2022 | — |
| CORRESP | Letter to the SEC | Sep 13, 2022 | — |
| F-4/A | Filing | Sep 13, 2022 | — |
| SEC STAFF LETTER | Filing | Aug 31, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 31, 2022 | — |
| 425 | Filing | Aug 29, 2022 | — |
| 425 | Filing | Aug 24, 2022 | — |
| 425 | Filing | Aug 24, 2022 | — |
| 425 | Filing | Aug 23, 2022 | — |
| 425 | Filing | Aug 19, 2022 | — |
| 425 | Filing | Aug 17, 2022 | — |
| 425 | Filing | Aug 16, 2022 | — |
| 425 | Filing | Aug 11, 2022 | — |
| 425 | Filing | Aug 11, 2022 | — |
| 425 | Filing | Aug 11, 2022 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NAMS (Nasdaq), NAMSW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Netherlands
- Headquarters
- Narrden, Netherlands
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1936258
- Former names
- NewAmsterdam Pharma Co B.V. (until Nov 22, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.